期刊文献+

慢病毒导入的PLCγ1 siRNA对人大肠癌细胞增殖和黏附的影响 被引量:1

Effection of lentiviral-delivered PLCγ1 siRNA on human colorectal carcinomas cell lines
暂未订购
导出
摘要 目的:制备在人大肠癌细胞系LoVo中稳定抑制PLCγ1(phospholiase C-gamma 1)的重组病毒,建立PLCγ1表达降低的细胞系,以便客观研究该基因的作用。方法:制备产生PLγ1 siRNA分子的重组慢病毒,在慢病毒感染LoVo细胞后以杀稻瘟菌素筛选稳定表达细胞系。应用Western-blot和RT-PCR对细胞中PLCγ1的蛋白和mRNA表达水平进行分析,XTT法和黏附能力测定分别检测其对细胞增殖和黏附的影响。结果:PLCγ1 siRNA显著下调了LoVo细胞中PLCγ1的表达,所构建的重组慢病毒导入的siRNA有较高的沉默效率,LoVo细胞的黏附能力显著降低,细胞增殖无明显改变。结论:研究证实了 PLCγ1基因可显著地影响大肠癌LoVo细胞的黏附能力,为利用PLCγ1介导的信号通路进行肿瘤基因治疗提供了实验依据。 Objective: To preare recombinant lentivirus stably suppressing PLCγ1 in human colorectal carcinomas LoVo celis, so as to establish LoVo cell lines deficient in PLCγ1 and to investigate the role of this gene. Methods:Reeombinant lentivirus produeeing PLCγ1 siRNA were prepared After LoVo cells were transduced with lentivirust, stably transduced cells were selected by Blasticidin. The protein and mRNA expression of PLCγ1 was examined by Western-blot and RT-PCR analysis. The effect of the lentivirus on the cell proliferation and cell adhesion was analyzed by XTT method and cell adhesion assay, respectively. Results: PLCγ1 siRNA knocked down PLCγ1 expression in LoVo cells obviously. The silenced efficiency of siRNA transducted by recombinant lentivirus was very high. Adhesion of human colorectal carcinomas LoVo cell Lines was significantly decreased, while proliferation was not affected. Conclusion: Our research confirm that PLCγ1 plays an important role in cell adhesion of colorectal carcinomas, and provides experimental evidences for targeting PLCγ1 in gene therapy against cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2006年第1期18-21,共4页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金(39870381)广东省自然科学基金(020015)广东省自然科学重点科学基金(05102580)
关键词 PLCγ1 慢病毒 小干扰RNA 黏附 增殖 PLCγ1 lentivirus siRNA adhesion proliferation
  • 相关文献

参考文献8

  • 1Burke B,Sumner S,Maitland N,et al.Macrophages in gene therapy:Cellular delivery vehicles and in vivo targets[J].J Leukoc Biol,2002,72(3):417-428.
  • 2Lee IH,You JO,Ha KS,et al.AHNAK-mediated activation of phospholipase Cγ1 through protein kinase C[J].J Biol Chem,2004,279(25):26645-26653.
  • 3Caplen NJ.RNAi as a gene therapy approach[J].Expert Opin Biol Ther,2003,3(4):575-586.
  • 4Cioca DP,Aoki Y,Kiyosawa K.RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines[J].Cancer Gene Ther,2003,10(2):125-133.
  • 5Noh DY,Lee YH,Kim SS,et al.Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues[J].Cancer,1994,73 (1):36-41.
  • 6朱晓伟.tadalafil[J].国外医学(药学分册),2003,30(2):125-125. 被引量:265
  • 7Chang JS,Iwashita S,Lee YH,et al.Transformation of rat fibroblasts by phospholipase C-gammal overexpression is accompanied by tyrosine dephosphorylation of paxillin[J].FEBS Lett,1999,460(1):161-165.
  • 8Wells A,Grandis JR.Phospholipase C-gammal in tumor progression[J].Clin Exp Metastasis,2003,20(4):285-290.

共引文献264

同被引文献24

  • 1Lin HY. Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1. Mol Ceil Biol, 1998, 18:3762-3770.
  • 2Tvorogov D. Integrin-dependent PLC-gammal phosphorylation mediates fibronectin-dependent adhesion. J Cell Sci, 2005, 118: 601-610.
  • 3Ye K, Snyder SH. PIKE GTPase: a novel mediator of phosphoinositide signaling. J Cell Sci, 2004, 117: 155-161.
  • 4Kobrinsky E. Receptor-mediated hydrolysis plasma membrane messenger PIP2 leads to K^+-curredesensitization. Nat Cell Biol,2: 507-514.
  • 5Patterson RL. Phospholipase C-gamma is required for agonistinduced Ca^2+ entry. Cell, 2002, 111 : 529-541.
  • 6Kitaura Y, Jang IK, Wang Y, et al. Conntrol of the B Cell-intrinsic tolerance program by c-Cbl and Cbl-b NIH public access author manuscript published in final edited form as: Immunity, 2007, 26:567-578.
  • 7Stohl W, Elliott JE, Hanilton AS, et al. Impaired recovery and cytolytic function of CD56^+ T and non-T ceils in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: studies in unselected patients and monozygotic disease-discordant twins.Arthritis Rheum, 1996, 39: 1840-1851.
  • 8Tsokos GC, Nambiar MP, Tenbrock K, et al. Rewiring the T cell signaling defects and novel prospects for the treanment of SLE. Trends Immunol, 2003, 24: 259-263.
  • 9Crispin JC, et al. T cell as therapeutic target in SLE. Nat Rev Rheumatol, 2010, 6: 317-325.
  • 10Kim YJ, Sekiya F, Poulin B, et al. Mechanism of B-cell receptor-induced phosphorylation and activation of phosphlipase C- gamma 2. Mol CeU Biol, 2004, 24: 9986-9999.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部